bay x 1005 has been researched along with 5-hydroxy-6,8,11,14-eicosatetraenoic acid in 1 studies
| Studies (bay x 1005) | Trials (bay x 1005) | Recent Studies (post-2010) (bay x 1005) | Studies (5-hydroxy-6,8,11,14-eicosatetraenoic acid) | Trials (5-hydroxy-6,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (5-hydroxy-6,8,11,14-eicosatetraenoic acid) |
|---|---|---|---|---|---|
| 58 | 6 | 8 | 648 | 5 | 54 |
| Protein | Taxonomy | bay x 1005 (IC50) | 5-hydroxy-6,8,11,14-eicosatetraenoic acid (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fruchtmann, R; Hatzelmann, A; Mohrs, KH; Müller-Peddinghaus, R; Raddatz, S | 1 |
1 other study(ies) available for bay x 1005 and 5-hydroxy-6,8,11,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds.
Topics: Animals; Arachidonic Acid; Binding Sites; Binding, Competitive; Cell-Free System; Humans; Hydroxyeicosatetraenoic Acids; Indoles; Kinetics; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Platelet Activating Factor; Quinolines; Rats; Structure-Activity Relationship; Subcellular Fractions | 1993 |